|Bid||336.60 x 1300|
|Ask||338.90 x 1800|
|Day's range||333.36 - 353.64|
|52-week range||58.81 - 464.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||09 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||332.87|
Baylor College of Medicine Assistant Professor Dr. Sara Andrabi joins Yahoo Finance to discuss the requirement of vaccinations for foreign travelers and other trends amid the COVID-19 pandemic.
Meg Fitzgerald, “Ascending Davos” Author and Columbia University Healthcare Policy Professor, joins Yahoo Finance Live to discuss the future of vaccines, the FDA rejecting Pfizer's booster shot for the general public and the importance of getting young children vaccinated as soon as possible.
What happened One of the more popular coronavirus stocks, Moderna (NASDAQ: MRNA), was struggling on Monday. Although it wasn't down by as much as the S&P 500 index, Moderna was still off by almost 2% in late afternoon trading.